Skip to main content
Top

Drugs

Issue 14/2021

Content (14 Articles)

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Stefan F. H. Neys, Jasper Rip, Rudi W. Hendriks, Odilia B. J. Corneth

Pharmacological Management of Acute Endodontic Pain

Asma A. Khan, Anibal Diogenes

Tralokinumab: First Approval

Sean Duggan

Savolitinib: First Approval

Anthony Markham

Telitacicept: First Approval

Sohita Dhillon

Belumosudil: First Approval

Hannah A. Blair

Imeglimin Hydrochloride: First Approval

Yvette N. Lamb

Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease

Jurij Hanzel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G. Feagan

Correction to: Aducanumab: First Approval

  • Correction

Sohita Dhillon

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images